Our COVID Vaccine Statement and other related resources for patients and our researchers and research staff are available on the COVID-19 Updates webpage.
Ronald Chen MD MPH
Open to Accrual
Cancer Care Delivery Research [CD]
To determine if the experimental arm (increased doses of SCP) has more patients who saw a primary care provider and had blood glucose and cholesterol checked in Year 2 (13-24 months) after finishing RT as compared to the control arm.
The participant must have a diagnosis of prostate adenocarcinoma that will be treated with RT plus ADT with curative intent. Both definitive RT (intact prostate) and post-prostatectomy RT patients are eligible.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.